Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 13/2003

01-07-2003 | Adis Drug Profile

Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix™)

A Viewpoint by Pierre Van Damme, Marie Van der Wielen and Heidi Theeten

Authors: Pierre Van Damme, Marie Van der Wielen, Heidi Theeten

Published in: Drugs | Issue 13/2003

Login to get access

Excerpt

Despite widespread infant vaccination against diphtheria, tetanus and pertussis, there is increasing evidence to suggest that adolescents and adults lose immunity to these diseases. Of major concern is the transmission of pertussis from an adult or adolescent source to unvaccinated or incompletely vaccinated infants. For these reasons, a new reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (dTpa; Boostrix™) has been developed. It is indicated for use as a booster dose in children (>4 years of age), adolescents and adults. …
Metadata
Title
Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix™)
A Viewpoint by Pierre Van Damme, Marie Van der Wielen and Heidi Theeten
Authors
Pierre Van Damme
Marie Van der Wielen
Heidi Theeten
Publication date
01-07-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue 13/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363130-00007

Other articles of this Issue 13/2003

Drugs 13/2003 Go to the issue

Adis Drug Profile

Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix™)

Adis Drug Evaluation

Tranexamic Acid

Therapy in Practice

Therapeutic Strategies in Common Variable Immunodeficiency

Adis Drug Profile

Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix™)

Review Article

Thiazolidinediones in Type 2 Diabetes Mellitus

Therapy in Practice

Current Concepts in Diabetic Gastroparesis